SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Complementary Health Practice Review
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gahlsdorf, T.
Right arrow Articles by Beal, M. W.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Efficacy of St. John's Wort for Treating Mild to Moderate Depression

Tera Gahlsdorf, MSN, APRN, BC

Inpatient Psychiatry, 4th floor, Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06519, tgahlsdorf@ hotmail.com

Robert Krause, MSN, APRN, BC

Quinnipiac University

Margaret W. Beal, PhD, CNM

Graduate Entry Pre-specialty in Nursing at the Yale University School of Nursing

Current studies regarding the efficacy of the herb St. John's wort (SJW) in treating mild to moderate cases of depression show conflicting evidence. In this article, we review the literature and consider similarities and differences between studies showing some efficacy and those showing none. Twelve published reports were reviewed. The majority of studies indicated the efficacy of SJW in the treatment of mild to moderate cases of depression. Most trials have had small sample sizes and either a placebo group or a standard pharmaceutical group. Two studies (both pediatric) were uncontrolled. Studies generally reported outcomes that had positive implications for their financial supporters and/or those with whom the primary investigators had acknowledged financial affiliations. More studies that have larger sample sizes and include placebo and pharmaceutical control groups are needed.

Key Words: St. John's Wort • hypericum • major depressive disorder • mild-moderate depression • complementary and alternative medicine

References

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
  • Bezchlibnyk-Butler, K., & Jeffries, J. (Ed.). (2004). Clinical handbook of psychotropic drugs (14th ed.) Toronto, Ontario, Canada: Hogrefe & Huber.
  • Bjerkenstedt, L., Edman, G., Gisberth Alken, R., & Mannel, M.( 2005). Hypericum extract LI 160 and fluoxetine in mild to moderate depression: A randomized, placebo-controlled multi-center study in outpatients. European Archives of Psychiatry and Clinical Neuroscience, 255, 40-47.[CrossRef][Medline] [Order article via Infotrieve]
  • Brenner, R., Azbel, V., Madhusoodanan S., & Pawlowska, M. (2000). Comparison of an extract of hypericum (li 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study. Clinical Therapeutics, 22, 411-419.[CrossRef][Medline] [Order article via Infotrieve]
  • Demyttenaere, K., Enzlin, P., Dewe, W., Boulanger, B., De Bie, J., De Troyer, W., et al. (2001). Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. Journal of Clinical Psychiatry, 62(suppl. 22), 30-33.
  • Engel, G. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129-196.[Abstract/Free Full Text]
  • Engel, G. (1980). The clinical application of the biopsychosocial model. The American Journal of Psychiatry, 137, 535-544.[Abstract/Free Full Text]
  • Fava, M., Alper, J., Nierenberg, A., Mischoulon, D., Otto, M., Zajecka, J., et al. (2005). A double-blind, randomized trial of St. John's wort, fluoxetine, and placebo in major depressive disorder. Journal of Clinical Psychopharmacology, 25, 441-447.[CrossRef][Medline] [Order article via Infotrieve]
  • Findling, R.L., McNamara, N.K., O'Riordan, M.A., Reed, M.D., Demeter, C.A., Branicky, L.A., et al. (2003). An open-label pilot study of St. John's wort in juvenile depression. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 908-914.[CrossRef][Medline] [Order article via Infotrieve]
  • Gastpar, M., Singer, A., & Zeller, K. (2005). Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. Pharmacopsychiatry, 38, 78-86.[CrossRef][Medline] [Order article via Infotrieve]
  • Gleitman, H. (1992). Basic psychology (3rd ed.). New York: W. W. Norton. (Original work published 1983)
  • Hobbs, C. (1997). St. John's wort: The mood enhancing herb. Loveland, CO: Interweave Press.
  • Hypericum Depression Trial Study Group. (2002 ). Effect of Hypericum perforatum (St John's wort) in major depressive disorder. JAMA, 287, 1807-1814.[Abstract/Free Full Text]
  • Kaehler, S., Sinner, C., Chatterjee, S., & Philippu, A. (1999). Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neuroscience Letters, 262, 199-202.[CrossRef][Medline] [Order article via Infotrieve]
  • Kalb, R., Trautmann-Sponsel, R., & Kieser, M. (2001). Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients: A randomized double-blind multicenter clinical trial. Pharmacopsychiatry, 34, 96-103.[CrossRef][Medline] [Order article via Infotrieve]
  • Lawvere, S., & Mahoney, M. (2005, December 1). St. John's wort. In A merican family physician. Retrieved December 31, 2005, from http://www.aafp.org/afp/20051201/2249.html
  • Lecrubier, Y., Clerc, G., Didi, R., & Kieser, M. (2002). Efficacy of St John's wort extract WS 5570 in major depression: A double-blind, placebo-controlled trial. American Journal of Psychiatry, 159, 1361-1366.[Abstract/Free Full Text]
  • Linde, K., Berner, M., Egger, M., & Mulrow, C. (2005). St. John's wort for depression. The British Journal of Psychiatry, 186, 99-107.[Abstract/Free Full Text]
  • Mischoulon, D., & Rosenbaum, J. (Eds.). (2002). Treatment of mood disorders. In Natural medications for psychiatric disorders: Considering the alternatives (pt. 2). Philadelphia, PA: Lippincott Williams & Wilkins.
  • National Center for Complementary and Alternative Medicine. (2002, April 9). Study shows St. John's wort ineffective for major depression of moderate severity. In N IH News Release. Retrieved February 4, 2005, from http://nccam.nih.gov/news/2002/stjohnswort/pressrelease.htm
  • National Center for Complementary and Alternative Medicine. (2004, July 16). Frequently asked questions. In St. John's wort and the treatment of depression. Retrieved February 27, 2005, from http://nccam.nih.gov/health/stjohnswort/
  • National Institute of Mental Health. (2005a, February 27). Depressive disorders. In The numbers count: Mental disorders in America. Retrieved February 27, 2005, from nimh.nih.gov/publicat/numbers.cfm
  • National Institute of Mental Health. (2005 b, February 27). The impact of mental illness on society. Retrieved February 27, 2005 from http://www.nimh.nih.gov/publicat/burden.cfm
  • NaturalStandard.com. (2005). Scientific evidence. In St. John's wort. Retrieved April 3, 2005, from http://www.naturalstandard.com/monographs/herbssupplements/patientstjohnswort.asp
  • Nickel, A.W., Kunzel, J.E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000). Effects of the high-affinity corticotropin-relearsing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. Journal of Psychiatric Research, 34, 171-181.[CrossRef][Medline] [Order article via Infotrieve]
  • Paul, I.A., & Skolnick, P. (2003). Glutamate and depression: Clinical and preclinical studies. Annals of the New York Academy of Sciences, 100(32), 50-72. Retrieved April 10, 2005, from http://www.neurotransmitter.net/depressionglutamate.htm[CrossRef]
  • Schrader, E. (2000). Equivalence of St John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression. International Clinical Psychopharmacology, 15, 61-68.[Medline] [Order article via Infotrieve]
  • Shelton, R.C., Keller, M.B., Gelenberg, A., Dunner, D.L., Hirschfeld, R., Thase, M.E., et al. (2001). Effectiveness of St John's wort in major depression: A randomized controlled trial. JAMA, 285, 1978-1986.[Abstract/Free Full Text]
  • Simeon, J., Nixon, M., Milin, R., Jovanovic, R., & Walker, S. (2005). Open-Label pilot study of St. John's wort in adolescent depression. Journal of Child and Adolescent Psychopharmacology, 15, 293-301.[CrossRef][Medline] [Order article via Infotrieve]
  • Trautmann-Sponsel, R., & Dienel, A. (2004). Safety of hypericum extract in mildly to moderately depressed outpatients: A review based on data from three randomized, placebo-controlled trials. Journal of Affective Disorders, 82, 303-307.[CrossRef][Medline] [Order article via Infotrieve]
  • Volz, H. (1997). Controlled clinical trials of hypericum extracts in depressed patients-an overview. Pharmacopsychiatry, 30(Suppl.), 72-76.[Medline] [Order article via Infotrieve]
  • Wagner, P., Jester, D., LeClair, B., Taylor, T., Woodward, L., & Lambert, J. (1999). Taking the edge off: Why patients choose St. John's wort. Journal of Family Practice, 48, 615-619.[Medline] [Order article via Infotrieve]
  • Woelk, H. (2000). Comparison of St John's wort and imipramine for treating depression: Randomised controlled trial. British Medical Journal, 321(7260), 536-539.[Abstract/Free Full Text]
  • World Health Organization. (2005, February 27). What is burden of disease?. In Burden of disease. Retrieved February 27, 2005, from http://www.3.who.int/whosis/faqs.cfm#003

Complementary Health Practice Review, Vol. 12, No. 3, 184-195 (2007)
DOI: 10.1177/1533210107306294


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gahlsdorf, T.
Right arrow Articles by Beal, M. W.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement